Aβ42/40 Ratio Assay

About Quanterix

Quanterix is a public company focused on advancing precision health through its groundbreaking Simoa technology, which allows for the detection of biomarkers at the single-molecule level. This capability is critical for early disease detection, monitoring, and therapeutic development, particularly in complex areas like neurodegenerative diseases. The company operates both as a technology platform provider, selling instruments and consumables, and as a diagnostic services partner, positioning itself at the forefront of the digital biomarker revolution.

Therapeutic Areas